Sim, S. H., Park, I. H., Jung, K. H., Kim, S., Ahn, J., Lee, K., . . . Ro, J. (2019). Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16). Br J Cancer.
Style de citation ChicagoSim, Sung Hoon, et al. "Randomised Phase 2 Study of Lapatinib and Vinorelbine Vs Vinorelbine in Patients With HER2 + metastatic Breast Cancer After Lapatinib and Trastuzumab Treatment (KCSG BR11-16)." Br J Cancer 2019.
Style de citation MLASim, Sung Hoon, et al. "Randomised Phase 2 Study of Lapatinib and Vinorelbine Vs Vinorelbine in Patients With HER2 + metastatic Breast Cancer After Lapatinib and Trastuzumab Treatment (KCSG BR11-16)." Br J Cancer 2019.